Journal Highlight : Cancer Genomics
The journal welcomes scholarly contributions related to the genomic characterization of cancer and the application of genomic technologies in cancer diagnosis, prognosis, treatment, and prevention. This section focuses on research that advances the understanding of genetic and genomic alterations involved in cancer initiation, progression, therapeutic response, and resistance mechanisms.
The journal encourages submissions in areas including Cancer Genomics, Tumor Genomic Profiling, Somatic and Germline Mutations, Cancer Genetics, Comparative Genomic Analysis, Whole Genome and Exome Sequencing, Transcriptomics, Epigenomics, Single-Cell Genomics, and Functional Genomics in Oncology. Research related to Oncogenes and Tumor Suppressor Genes, Copy Number Variations, Gene Expression Signatures, Non-Coding RNA in Cancer, Cancer Evolution and Heterogeneity, and Liquid Biopsy Genomics is also welcomed.
Submissions focusing on Precision Oncology, Pharmacogenomics, Biomarker Discovery and Validation, Genomic Predictors of Treatment Response, Cancer Risk Assessment, AI and Bioinformatics in Cancer Genomics, Molecular Diagnostics, and Clinical Applications of Genomic Medicine are encouraged. The journal also welcomes studies investigating genomic determinants of metastasis, recurrence, therapeutic resistance, and personalized cancer treatment strategies.
Accepted manuscript types include Original Research Articles, Systematic Reviews, Meta-Analyses, Experimental Studies, Translational Research Articles, Clinical Genomic Studies, Case Reports, and Bioinformatics and Computational Oncology Studies that contribute to advancements in cancer genomics and molecular cancer research.
Through this focus area, the journal aims to support research that expands genomic understanding of cancer biology, advances precision cancer medicine, improves molecular diagnostics and targeted therapies, and contributes to innovative and evidence-based oncology care worldwide.
